Sterling begins large-scale silica production for Nanologica
Sterling begins manufacturing of $14m worth of silica particles as preparative chromatography media, after deal with Chinese distributor.
Archives for August 29, 2019
IND approval gives celiac patients possibility to eat gluten
The FDA approves an IND application from ActoBio for AG017, an oral biologic drug candidate for the reversal of celiac disease, a condition which currently has no approved treatments.